SPONSOR
Nanjing Legend Biotech Co.
Total Trials
2
Recruiting
2
Phases
EARLY_Phase 1, Phase 1
Conditions studied: Relapsed/Refractory Autoimmune DiseasesSystemic Lupus Erythematosus (SLE)Idiopathic Inflammatory Myopathies(IIM)
Nanjing Legend Biotech Co. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Relapsed/Refractory Autoimmune Diseases, Systemic Lupus Erythematosus (SLE), Idiopathic Inflammatory Myopathies(IIM).
The trial portfolio spans EARLY_Phase 1, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Nanjing Legend Biotech Co.
How many clinical trials has Nanjing Legend Biotech Co. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Nanjing Legend Biotech Co., of which 2 are actively recruiting participants. These trials cover conditions including Relapsed/Refractory Autoimmune Diseases, Systemic Lupus Erythematosus (SLE), Idiopathic Inflammatory Myopathies(IIM). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Nanjing Legend Biotech Co. research focus on?
Nanjing Legend Biotech Co. clinical trials span Relapsed/Refractory Autoimmune Diseases, Systemic Lupus Erythematosus (SLE), Idiopathic Inflammatory Myopathies(IIM). The research pipeline includes EARLY_Phase 1, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Nanjing Legend Biotech Co. clinical trial?
To participate in a Nanjing Legend Biotech Co. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Nanjing Legend Biotech Co. trials with current recruitment status updated daily.
Clinical Trials by Nanjing Legend Biotech Co.
NCT07095075 EARLY_Phase 1
Recruiting
A Study of LUCAR-DKS1 in Subjects With Relapsed/Refractory Autoimmune Diseases
Relapsed/Refractory Autoimmune Diseases
NCT07331272 Phase 1
Recruiting
A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM)
Systemic Lupus Erythematosus (SLE)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology